2017-2022 Global and Japan Antiulcer drugs Market Analysis Report

Published: Jul, 2017 | Pages: 124 | Publisher: JP Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global Antiulcer drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Antiulcer drugs market's development status and future trend in Japan, focuses on top players in Japan, also splits Antiulcer drugs market by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players include
Astellas Pharma Inc.
JEAN-MARIE PHARMACAL CO. LTD
AstraZeneca AB
Hanmi Pharm. Co., Ltd
Enal Drugs Pvt. Ltd.
Takeda Pharmaceutical Company Limited
Metrochem API Pvt. Ltd
Nang Kuang Pharmacutical Co.,Ltd
Bright Future Pharmaceuticals Factory
Dr.Reddy`s Laboratories Limited
Eisai Co.,Ltd.
KYOWA CHEMICAL INDUSTRY CO.,LTD.
Dead Sea Bromine Company Ltd.(Magnesia Products SBU)
Scora S.A.
Yonsung Fine Chemicals Co.,Ltd.
PHARMACIA LIMITED
Everlight Chemical Industrial Corporation.
TOWA PHARMACEUTICAL CO., LTD.
DAIICHI SANKYO ESPHA CO., LTD.
Nichi-iko Pharmaceutical Co.,Ltd
Sawai Pharmaceutical Co.,Ltd.
OHARA Pharmaceutical Co.,Ltd.
Teva Takeda Pharma Ltd.
Elmed Eisai Co., Ltd.
NIPRO CORPORATION
KOKANOD PHARMACEUTICAL CO.,LTD.
SANWA KAGAKU KENKYUSHO CO.,LTD.

Geographically, this report splits the Japan market into 5 regions:
Tokyo
Yokohama
Osaka
Nagoya
Others

On the basis of product, the Antiulcer drugs market is primarily split into
Antiulcer drugs Market, by H2 receptor antagonist
Ranitidine
Famotidine
Cimetidine
Nizatidine
Roxatidine
Ebrotidine
Lafutidine
Mifentidine
Antiulcer drugs Market, by H+-K+-ATP enzyme inhibitor
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole
Tenatoprazole
Esomeprazole
Ilaprazole
Tenprazole
Disuprazole
Leminoprazole
Antiulcer drugs Market, by Others
Aluminum hydroxide
Colloidal Bismuth Pectin
Sucralfate
Vitamin U Belladonna and Al
bismuth potassium citrate
sodium bicarbonate
calcium carbonate
magnesium oxide
Glycopyrrolate
Cascara
Pirenzepine
Gastridine
Magnesium trisilicate
Misoprostol

Key Applications
Digestive Department
Internal medicine
Pharmacy
Clinic

 Table of Contents

2017-2022 Global and Japan Antiulcer drugs Market Analysis Report
1 Antiulcer drugs Overview
    1.1 Product Overview and Scope of Antiulcer drugs
    1.2 Japan Antiulcer drugs Market by Applications/End Users
        1.2.1 Japan Antiulcer drugs Sales () and Market Share Comparison by Applications (2012-2022)
        1.2.2 Digestive Department
        1.2.3 Internal medicine
        1.2.4 Pharmacy
        1.2.5 Clinic
    1.3 Japan Antiulcer drugs Market by Regions
        1.3.1 Japan Antiulcer drugs Market Size (Million USD) Comparison by Regions (2012-2022)
        1.3.2 Tokyo Antiulcer drugs Status and Prospect (2012-2022)
        1.3.3 Yokohama Antiulcer drugs Status and Prospect (2012-2022)
        1.3.4 Osaka Antiulcer drugs Status and Prospect (2012-2022)
        1.3.5 Nagoya Antiulcer drugs Status and Prospect (2012-2022)
        1.3.6 Others in Japan Antiulcer drugs Status and Prospect (2012-2022)
    1.4 Japan Market Size (Sales and Revenue) of Antiulcer drugs (2012-2022)
        1.4.1 Japan Antiulcer drugs Sales () and Growth Rate (%)(2012-2022)
        1.4.2 Japan Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    1.5 Classification of Antiulcer drugs by H2 receptor antagonist
        1.5.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
        1.5.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
        1.5.3 Ranitidine
        1.5.4 Famotidine
        1.5.5 Cimetidine
        1.5.6 Nizatidine
        1.5.7 Roxatidine
    1.6 Classification of Antiulcer drugs by H+-K+-ATP enzyme inhibitor
        1.6.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
        1.6.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
        1.6.3 Omeprazole
        1.6.4 Lansoprazole
        1.6.5 Pantoprazole
        1.6.6 Rabeprazole
        1.6.7 Tenatoprazole
    1.7 Classification of Antiulcer drugs by Others
        1.7.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
        1.7.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
        1.7.3 Aluminum hydroxide
        1.7.4 Colloidal Bismuth Pectin
        1.7.5 Sucralfate
        1.7.6 Vitamin U Belladonna and Al
        1.7.7 bismuth potassium citrate

2 Japan Antiulcer drugs Market Competition by Players/Manufacturers
    2.1 Japan Antiulcer drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 Japan Antiulcer drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 Japan Antiulcer drugs Average Price () by Players/Manufacturers (2012-2017)
    2.4 Japan Antiulcer drugs Market Competitive Situation and Trends
        2.4.1 Japan Antiulcer drugs Market Concentration Rate
        2.4.2 Japan Antiulcer drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in Japan Market
    2.5 Japan Players/Manufacturers Antiulcer drugs Manufacturing Base Distribution, Sales Area, Product Types

3 Japan Antiulcer drugs Sales and Revenue by Regions (2012-2017)
    3.1 Japan Antiulcer drugs Sales () and Market Share by Regions (2012-2017)
    3.2 Japan Antiulcer drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
    3.3 Japan Antiulcer drugs Price () by Regions (2012-2017)

4 Japan Antiulcer drugs Sales and Revenue by Type/ Product Category (2012-2017)
    4.1 Japan Antiulcer drugs Sales () and Market Share by Type (2012-2017)
    4.2 Japan Antiulcer drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 Japan Antiulcer drugs Price () by Type (2012-2017)
    4.4 Japan Antiulcer drugs Sales Growth Rate (%) by Type (2012-2017)

5 Japan Antiulcer drugs Sales by Application (2012-2017)
    5.1 Japan Antiulcer drugs Sales () and Market Share by Applications (2012-2017)
    5.2 Japan Antiulcer drugs Sales Growth Rate (%) by Applications (2012-2017)
    5.3 Market Drivers and Opportunities

6 Japan Antiulcer drugs Players/Manufacturers Profiles and Sales Data
    6.1 Astellas Pharma Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Antiulcer drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Astellas Pharma Inc. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 JEAN-MARIE PHARMACAL CO. LTD
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Antiulcer drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 AstraZeneca AB
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Antiulcer drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 AstraZeneca AB Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Hanmi Pharm. Co., Ltd
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Antiulcer drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Hanmi Pharm. Co., Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Enal Drugs Pvt. Ltd.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Antiulcer drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Enal Drugs Pvt. Ltd. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Takeda Pharmaceutical Company Limited
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Antiulcer drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Takeda Pharmaceutical Company Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Metrochem API Pvt. Ltd
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Antiulcer drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Metrochem API Pvt. Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Nang Kuang Pharmacutical Co.,Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Antiulcer drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bright Future Pharmaceuticals Factory
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Antiulcer drugs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bright Future Pharmaceuticals Factory Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Dr.Reddy`s Laboratories Limited
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Antiulcer drugs Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Dr.Reddy`s Laboratories Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Eisai Co.,Ltd.
    6.12 KYOWA CHEMICAL INDUSTRY CO.,LTD.
    6.13 Dead Sea Bromine Company Ltd.(Magnesia Products SBU)
    6.14 Scora S.A.
    6.15 Yonsung Fine Chemicals Co.,Ltd.
    6.16 PHARMACIA LIMITED
    6.17 Everlight Chemical Industrial Corporation.
    6.18 TOWA PHARMACEUTICAL CO., LTD.
    6.19 DAIICHI SANKYO ESPHA CO., LTD.
    6.20 Nichi-iko Pharmaceutical Co.,Ltd
    6.21 Sawai Pharmaceutical Co.,Ltd.
    6.22 OHARA Pharmaceutical Co.,Ltd.
    6.23 Teva Takeda Pharma Ltd.
    6.24 Elmed Eisai Co., Ltd.
    6.25 NIPRO CORPORATION
    6.26 KOKANOD PHARMACEUTICAL CO.,LTD.
    6.27 SANWA KAGAKU KENKYUSHO CO.,LTD.

7 Antiulcer drugs Manufacturing Cost Analysis
    7.1 Antiulcer drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Antiulcer drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Antiulcer drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Antiulcer drugs Major Players/Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 Japan Antiulcer drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Japan Antiulcer drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 Japan Antiulcer drugs Sales () Forecast by Type (2017-2022)
    11.3 Japan Antiulcer drugs Sales () Forecast by Application (2017-2022)
    11.4 Japan Antiulcer drugs Sales () Forecast by Regions (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables and Figures

    Figure Global and Japan Market Size (Million USD) Comparison 2012-2022
    Table Antiulcer drugs Sales () and Revenue (Million USD) Market Split by H2 receptor antagonist
    Table Antiulcer drugs Sales () and Revenue (Million USD) Market Split by H+-K+-ATP enzyme inhibitor
    Table Antiulcer drugs Sales () and Revenue (Million USD) Market Split by Others
    Table Antiulcer drugs Sales () by Application (2016-2022)
    Figure Product Picture of Antiulcer drugs
    Table Japan Antiulcer drugs Sales () Comparison by Applications (2012-2022)
    Figure Japan Sales Market Share (%) of Antiulcer drugs by Applications in 2016
    Figure Digestive Department Examples
    Table Key Downstream Customer in Digestive Department
    Figure Internal medicine Examples
    Table Key Downstream Customer in Internal medicine
    Figure Pharmacy Examples
    Table Key Downstream Customer in Pharmacy
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Tokyo Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Yokohama Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Osaka Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Nagoya Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Others in Japan Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Antiulcer drugs Sales () and Growth Rate (%) (2012-2022)
    Figure Japan Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Table Japan Antiulcer drugs Sales () and Growth Rate (%) Comparison by H2 receptor antagonist (2012-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share by H2 receptor antagonist in 2016
    Figure Ranitidine Product Picture
    Figure Famotidine Product Picture
    Figure Cimetidine Product Picture
    Figure Nizatidine Product Picture
    Figure Roxatidine Product Picture
    Table Japan Antiulcer drugs Sales () and Growth Rate (%) Comparison by H+-K+-ATP enzyme inhibitor (2012-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share by H+-K+-ATP enzyme inhibitor in 2016
    Figure Omeprazole Product Picture
    Figure Lansoprazole Product Picture
    Figure Pantoprazole Product Picture
    Figure Rabeprazole Product Picture
    Figure Tenatoprazole Product Picture
    Table Japan Antiulcer drugs Sales () and Growth Rate (%) Comparison by Others (2012-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share by Others in 2016
    Figure Aluminum hydroxide Product Picture
    Figure Colloidal Bismuth Pectin Product Picture
    Figure Sucralfate Product Picture
    Figure Vitamin U Belladonna and Al Product Picture
    Figure bismuth potassium citrate Product Picture
    Table Japan Antiulcer drugs Sales of Key Players/Manufacturers (2012-2017)
    Table Japan Antiulcer drugs Sales Share (%) by Players/Manufacturers (2012-2017)
    Figure 2016 Japan Antiulcer drugs Sales Share (%) by Players/Manufacturers
    Figure 2017 Japan Antiulcer drugs Sales Share (%) by Players/Manufacturers
    Table Japan Antiulcer drugs Revenue by Players/Manufacturers (2012-2017)
    Table Japan Antiulcer drugs Revenue Market Share (%) by Players/Manufacturers (2012-2017)
    Figure 2016 Japan Antiulcer drugs Revenue Market Share (%) by Players/Manufacturers
    Figure 2017 Japan Antiulcer drugs Revenue Market Share (%) by Players/Manufacturers
    Table Japan Market Antiulcer drugs Average Price of Key Players/Manufacturers (2012-2017)
    Figure Japan Market Antiulcer drugs Average Price of Key Players/Manufacturers in 2016
    Figure Japan Antiulcer drugs Market Share of Top 3 Players/Manufacturers
    Figure Japan Antiulcer drugs Market Share of Top 5 Players/Manufacturers
    Table Japan Players/Manufacturers Antiulcer drugs Manufacturing Base Distribution and Sales Area
    Table Japan Players/Manufacturers Antiulcer drugs Product Category
    Table Japan Antiulcer drugs Sales () by Regions (2012-2017)
    Table Japan Antiulcer drugs Sales Share (%) by Regions (2012-2017)
    Figure Japan Antiulcer drugs Sales Share (%) by Regions (2012-2017)
    Figure Japan Antiulcer drugs Sales Market Share (%) by Regions in 2016
    Table Japan Antiulcer drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Japan Antiulcer drugs Revenue Market Share (%) by Regions (2012-2017)
    Figure Japan Antiulcer drugs Revenue Market Share (%) by Regions (2012-2017)
    Figure Japan Antiulcer drugs Revenue Market Share (%) by Regions in 2016
    Table Japan Antiulcer drugs Price (USD/Unit) by Regions (2012-2017)
    Table Japan Antiulcer drugs Sales () by Type (2012-2017)
    Table Japan Antiulcer drugs Sales Share (%) by Type (2012-2017)
    Figure Japan Antiulcer drugs Sales Share (%) by Type (2012-2017)
    Figure Japan Antiulcer drugs Sales Market Share (%) by Type in 2016
    Table Japan Antiulcer drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Japan Antiulcer drugs Revenue Market Share (%) by Type (2012-2017)
    Figure Revenue Market Share of Antiulcer drugs by Type (2012-2017)
    Figure Revenue Market Share of Antiulcer drugs by Type in 2016
    Table Japan Antiulcer drugs Price (USD/Unit) by Types (2012-2017)
    Figure Japan Antiulcer drugs Sales Growth Rate (%) by Type (2012-2017)
    Table Japan Antiulcer drugs Sales () by Applications (2012-2017)
    Table Japan Antiulcer drugs Sales Market Share (%) by Applications (2012-2017)
    Figure Japan Antiulcer drugs Sales Market Share (%) by Applications (2012-2017)
    Figure Japan Antiulcer drugs Sales Market Share (%) by Applications in 2016
    Table Japan Antiulcer drugs Sales Growth Rate (%) by Applications (2012-2017)
    Figure Japan Antiulcer drugs Sales Growth Rate (%) by Applications (2012-2017)
    Table Astellas Pharma Inc. Basic Information List
    Table Astellas Pharma Inc. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Astellas Pharma Inc. Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Astellas Pharma Inc. Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Astellas Pharma Inc. Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table JEAN-MARIE PHARMACAL CO. LTD Basic Information List
    Table JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AstraZeneca AB Basic Information List
    Table AstraZeneca AB Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AstraZeneca AB Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table AstraZeneca AB Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AstraZeneca AB Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Hanmi Pharm. Co., Ltd Basic Information List
    Table Hanmi Pharm. Co., Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Hanmi Pharm. Co., Ltd Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Hanmi Pharm. Co., Ltd Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Hanmi Pharm. Co., Ltd Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Enal Drugs Pvt. Ltd. Basic Information List
    Table Enal Drugs Pvt. Ltd. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Enal Drugs Pvt. Ltd. Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Enal Drugs Pvt. Ltd. Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Enal Drugs Pvt. Ltd. Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Takeda Pharmaceutical Company Limited Basic Information List
    Table Takeda Pharmaceutical Company Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Takeda Pharmaceutical Company Limited Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Takeda Pharmaceutical Company Limited Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Takeda Pharmaceutical Company Limited Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Metrochem API Pvt. Ltd Basic Information List
    Table Metrochem API Pvt. Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Metrochem API Pvt. Ltd Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Metrochem API Pvt. Ltd Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Metrochem API Pvt. Ltd Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Nang Kuang Pharmacutical Co.,Ltd Basic Information List
    Table Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Bright Future Pharmaceuticals Factory Basic Information List
    Table Bright Future Pharmaceuticals Factory Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Bright Future Pharmaceuticals Factory Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Bright Future Pharmaceuticals Factory Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Bright Future Pharmaceuticals Factory Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Dr.Reddy`s Laboratories Limited Basic Information List
    Table Dr.Reddy`s Laboratories Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table Dr.Reddy`s Laboratories Limited Antiulcer drugs Sales Growth Rate (%)(2012-2017)
    Table Dr.Reddy`s Laboratories Limited Antiulcer drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Dr.Reddy`s Laboratories Limited Antiulcer drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Eisai Co.,Ltd. Basic Information List
    Table KYOWA CHEMICAL INDUSTRY CO.,LTD. Basic Information List
    Table Dead Sea Bromine Company Ltd.(Magnesia Products SBU) Basic Information List
    Table Scora S.A. Basic Information List
    Table Yonsung Fine Chemicals Co.,Ltd. Basic Information List
    Table PHARMACIA LIMITED Basic Information List
    Table Everlight Chemical Industrial Corporation. Basic Information List
    Table TOWA PHARMACEUTICAL CO., LTD. Basic Information List
    Table DAIICHI SANKYO ESPHA CO., LTD. Basic Information List
    Table Nichi-iko Pharmaceutical Co.,Ltd Basic Information List
    Table Sawai Pharmaceutical Co.,Ltd. Basic Information List
    Table OHARA Pharmaceutical Co.,Ltd. Basic Information List
    Table Teva Takeda Pharma Ltd. Basic Information List
    Table Elmed Eisai Co., Ltd. Basic Information List
    Table NIPRO CORPORATION Basic Information List
    Table KOKANOD PHARMACEUTICAL CO.,LTD. Basic Information List
    Table SANWA KAGAKU KENKYUSHO CO.,LTD. Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Antiulcer drugs
    Figure Manufacturing Process Analysis of Antiulcer drugs
    Figure Antiulcer drugs Industrial Chain Analysis
    Table Raw Materials Sources of Antiulcer drugs Major Players/Manufacturers in 2016
    Table Major Buyers of Antiulcer drugs
    Table Distributors/Traders List
    Figure Japan Antiulcer drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Japan Antiulcer drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Antiulcer drugs Price () Trend Forecast (2017-2022)
    Table Japan Antiulcer drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Antiulcer drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share Forecast by Type in 2022
    Table Japan Antiulcer drugs Sales () Forecast by Application (2017-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Japan Antiulcer drugs Sales Volume Market Share Forecast by Application in 2022
    Table Japan Antiulcer drugs Sales () Forecast by Regions (2017-2022)
    Table Japan Antiulcer drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan Antiulcer drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan Antiulcer drugs Sales Volume Share Forecast by Regions in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources